Nvest Wealth Strategies, Inc.

Position in NVO — Novo Nordisk A S

CIK 2106942 POWELL, OH

Position in NVO

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$431

+$101 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,341

of 1,348 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Nvest Wealth Strategies, Inc. holds $182,342 across 7 Drug Manufacturers - General names. NVO ranks #7 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	274	$69,587
2	ABBV	AbbVie Inc.	227	$57,122
3	LLY	ELI LILLY & Co	39	$46,777
4	BIIB	Biogen Inc.	22	$4,753
5	GSK	GSK plc	48	$2,516
6	MRK	Merck & Co., Inc.	9	$1,156
7	NVO	Novo Nordisk A S This page	9	$431

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$431	9	0.0%	Shares	Other	2026-07-10
2026-03-31	$330	9	0.0%	Shares	Other	2026-04-13
2025-12-31	$457	9	—	Shares	Sole	2026-01-28
No filing history on record for this holder in this stock.